G01N 2333/91091
Glycosyltransferases
Official title: Glycosyltransferases (2.4)
G01N2333/91091 (Glycosyltransferases) appears on 154 US grants and 319 published applications in this corpus.
Search patents in G01N- Granted patents
- 154
- Published applications
- 319
- Assignees
- 204
- Inventors
- 679
- Latest grant
- 23 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 3 | 0 |
| 2000 | 2 | 0 |
| 2001 | 3 | 0 |
| 2002 | 3 | 6 |
| 2003 | 1 | 15 |
| 2004 | 2 | 9 |
| 2005 | 5 | 5 |
| 2006 | 5 | 9 |
| 2007 | 1 | 9 |
| 2008 | 2 | 7 |
| 2009 | 3 | 12 |
| 2010 | 4 | 11 |
| 2011 | 2 | 21 |
| 2012 | 7 | 12 |
| 2013 | 8 | 17 |
| 2014 | 4 | 7 |
| 2015 | 7 | 22 |
| 2016 | 14 | 28 |
| 2017 | 9 | 15 |
| 2018 | 11 | 16 |
| 2019 | 9 | 13 |
| 2020 | 10 | 13 |
| 2021 | 9 | 19 |
| 2022 | 7 | 10 |
| 2023 | 2 | 7 |
| 2024 | 7 | 21 |
| 2025 | 10 | 6 |
| 2026 | 0 | 9 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Markers and their use in brain injury23 Sep 2025US 12,422,442 B2Fundació Hospital Universitari Vall D'Hebron—Institut De Recerca
- Methods and materials for assessing response to plasmablast- and plasma cell-depleting therapies19 Aug 2025US 12,391,765 B2Takeda Pharmaceutical Company Limited
- Biomarkers for predicting prostate cancer progression15 Jul 2025US 12,359,259 B2Academia Sinica
- FAMIN assay methods17 Jun 2025US 12,331,343 B2Cambridge Enterprise Limited
- Detection of PAR in the CSF of patients with Parkinson's disease15 Apr 2025US 12,276,657 B2The Johns Hopkins University
- High-throughput method for screening alpha-1,2-fucosyltransferase and screened mutant13 Aug 2026US 2026/0234693 A1Jiangnan University
- Direct methylation single-base resolution sequencing of enriched unmethylated dna11 Jun 2026US 2026/0159882 A1Guardant Health, Inc.
- Antibodies against human cd384 Jun 2026US 2026/0152566 A1Genmab A/S
- Compositions and methods for production of exofucosylated cells for clinical applications23 Apr 2026US 2026/0109950 A1
- Metal nanoparticle, and plasmonic biosensor comprising the same9 Apr 2026US 2026/0098867 A1Korea University Research and Business Foundation
Most cited
By later US patents
- Antibodies against CD38 for treatment of multiple myeloma94US 7,829,673 B2Genmab A/S · 2010
- Conductance of improperly folded proteins through the secretory pathway29US 6,344,475 B12002
- Bacterial transglycosylases: assays for monitoring the activity using Lipid II substrates analogs and methods for discovering new antibiotics26US 6,461,829 B1The Trustees of Princeton University · 2002
- Affinity ultrafiltration assay for transferase activity14US 5,869,275 A1999
- Device and method for detection of analytes13US 8,343,726 B2Techlab, Inc. · 2013